Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified

Abstract Acute leukemias of ambiguous lineage, not otherwise specified (ALAL-NOS) is a rare type of acute leukemia. Management of relapse/refractory (R/R) patients is still challenging.traditional chemotherapy treatment is not effective. In this paper, we reported 6 R/R patients diagnosed as ALAL-NO...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Kaiqi Liu, Yan Li, Shaowei Qiu, Chunlin Zhou, Shuning Wei, Dong Lin, Guangji Zhang, Hui Wei, Ying Wang, Bingcheng Liu, Xiaoyuan Gong, Qiuyun Fang, Yang Song, Huijun Wang, Chengwen Li, Qinghua Li, Lihua Wu, Benfa Gong, Yuntao Liu, Jianxiang Wang, Yingchang Mi
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2021-09-01
Serija:	Experimental Hematology & Oncology
Teme:	Efficacy venetoclax ALAL-NOS Relapse Refractory
Online dostop:	https://doi.org/10.1186/s40164-021-00239-w
Oznake:	Označite Brez oznak, prvi označite!